Opendata, web and dolomites

REBOOT SIGNED

First-in-class implants for bone regeneration surgery after a bone, ligament or tendon injury

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 REBOOT project word cloud

Explore the words cloud of the REBOOT project. It provides you a very rough idea of what is the project "REBOOT" about.

injury    experiencing    re    screw    msds    inflammation    msd    mixed    validated    bones    transition    sales    capablity    feasibility    fragile    biocomposite    surgery    bioresorbable    orthopaedic    turnover    surgical    community    enter    spiral    15    perspectives    injuries    first    patients    noraker    operation    ligaments    disruptive    polymer    instrument    develops    formula    follow    trauma    days    implants    adoption    cruciate    world    life    action    worldwide    billions    revision    regenerative    musculoskeletal    too    poor    break    million    launch    20    market    metallic    glass    full    international    revolutionary       population    outcomes    multiplied    suffering    ceramic    made    imperfect    class    bone    2018    sme    healing    industrial    reboot    quality    30    synthetic    rate    knee    bioabsorbable    bioactive    millions    marketed    leaving    functional    create    weights    structure    manufacturing    shows    disorders    ligament    recreate    pain    materials    toward    tendon    native    chronic    100    regeneration    abnormal    2015    patented    ages    people   

Project "REBOOT" data sheet

The following table provides information about the project.

Coordinator
NORAKER 

Organization address
address: 11/13 AVENUE ALBERT EINSTEIN CENTRE SCIENTIFIQUE ET TECHNOLOGIQUE
city: VILLEURBANNE
postcode: 69100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 3˙545˙000 €
 EC max contribution 2˙481˙500 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2021-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NORAKER FR (VILLEURBANNE) coordinator 2˙481˙500.00

Map

 Project objective

NORAKER develops first-in-class implants for regenerative orthopaedic surgery to offer full healing to patients suffering from a bone, ligament or tendon injury. With project REBOOT, NORAKER will create the market of bone regeneration surgery. Each year in Europe, 1,6 million people require orthopaedic surgery after a bone, ligament or tendon injury, with many more cases expected as population ages. The current implants (made of metallic or bioresorbable materials) show imperfect healing outcomes, leaving millions of patients with fragile bones and poor quality of life (with 30% of inflammation, 20% of revision surgery and millions suffering from chronic pain and musculoskeletal disorders, MSDs). It weights billions of follow-up costs on the community. Enter NORAKER’s biocomposite surgical implants, made of bioactive glass – a revolutionary ceramic – mixed with a synthetic polymer, both bioabsorbable. This technology shows disruptive regeneration action: it can recreate up to 100% of the native-like functional bone structure with no inflammation, no abnormal pain, no MSD and a very low re-operation rate (4%). Today this patented technology is adapted to knee cruciate ligaments regeneration (with a world-first biocomposite screw marketed in 2015). In a SME Instrument Phase 1 project (2018), NORAKER has validated the feasibility of a new biocomposite formula with broader perspectives of regeneration for tendon, ligament and bone injuries. The Phase 2 project will do the industrial scale-up of this biocomposite and launch the industrial production of the first range of implants for the bone trauma market. Their adoption will support the transition toward regenerative orthopaedic surgery and break the spiral of pain and MSDs, which too many patients are experiencing these days. With this disruptive offer, NORAKER will become a scale-up operating worldwide, with a large manufacturing capablity, international sales and turnover multiplied by 15 in five years.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REBOOT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REBOOT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More